STUDY: Widely used HPV injection linked to 4 AUTOIMMUNE DISORDERS

03/21/2024 / By Ava Grace

A widely used human papillomavirus (HPV) vaccine appears to be linked to four autoimmune disorders, according to a new study.

The study published March 7 in Vaccine compared the health records of nearly two million unvaccinated and vaccinated girls in the South American nation of Colombia over a 10-year period. The vaccinated girls were injected with a quadrivalent vaccine that targets four HPV strains. It found that, compared to their unvaccinated counterparts, the vaccinated girls were:

4.4 times more likely to develop rheumatoid arthritis
2.76 times more likely to develop juvenile idiopathic arthritis
2.86 times more likely to develop thyrotoxicosis
2.54 times more likely to develop idiopathic thrombocytopenic purpura

While the study did not name the quadrivalent vaccine used, it was reportedly widely used globally except the United States. Quadrivalent vaccines target four high-risk strains of HPV, while Merck’s Gardasil 9 vaccine – the only one distributed in the U.S. – targets nine strains. Merck does make a quadrivalent Gardasil vaccine, one of two licensed by the World Health Organization (WHO).

According to the study authors, HPV vaccination rates in Colombia are extremely low due to the “lack of an efficacious screening program,” “lack of timely access to the health system in remote areas” and “widespread public misinformation regarding primary prevention in the adolescent population.”

They also cited “mistrust” that intensified in 2014 after 500 vaccinated girls in a small town called Carmen de Bolivar in the country’s Bolivar department – with videos of the girls being widely shared on the internet – reported adverse symptoms, including headache, paresthesia (tingling or prickling sensation on the extremities), shortness of breath, chest pain and fainting. (Related: Federal “Vaccine Court”: Gardasil jab for HPV irrefutably linked to NARCOLEPSY.)

As public confidence in the vaccine plummeted, rates went from 80 percent of girls in 2012 to 14 percent and 5 percent for the first and second doses in 2016.

Colombian study proves that vaccines are far from being safe

“This is a stunning admission of the immune dysregulation caused by this vaccine,” said Children’s Health Defense (CHD) Chief Scientific Officer Brian Hooker. “At a minimum, this deserves more comprehensive investigation towards a decision whether to pull the vaccine entirely.”

“There are significantly higher levels of these four autoimmune disorders – in girls who weren’t diagnosed with the disorders before vaccination – in the vaccinated group. In other words, these significant odds ratios speak for themselves.”

According to CHD, the March 7 study “adds to a large body of peer-reviewed scientific literature from the U.S., Australia, Denmark and Sweden, France, Japan and Colombia and statistics published by public health agencies in each of these countries demonstrating associations between HPV vaccination and autoimmune conditions.”

Even the authors themselves acknowledged the lack of local studies to say that the quadrivalent HPV vaccine is indeed safe and effective.

Interestingly, the study was published on the final day of the Global Cervical Cancer Elimination Forum, held last March 5 to 7 at the Colombian city of Cartagena de Indias. Bogota reportedly hosted the event as part of its commitment to catalyze national and global momentum “to eliminate cervical cancer,” as per CHD. The Bill and Melinda Gates Foundation, United Nations Children’s Fund (UNICEF) and the World Bank committed nearly $600 million to expand global vaccination, screening and treatment in multiple countries, including Colombia.

Visit Vaccines.news for more similar stories.

Watch this 2013 clip of journalist Katie Couric touching on the HPV vaccine controversy.

This video is from the Random Nobody channel on Brighteon.com.